Alzheimer's Disease in the Middle-Aged

Description:

Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory problems and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years.
Current research is aimed at understanding why AD occurs and who is at greatest risk of developing it, improving the accuracy of diagnosis and the ability to identify those at risk, discovering, developing, and testing new treatments, and discovering treatments for behavioral problems in patients with AD. This new book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.

Table of Contents:

Preface

Chapter 1 - Mild Cognitive Impairment: Current Trends for Early Detection and Treatment; pp. 1-66
(Jena Kravitz, UCLA Semel Institute Aging & Memory Research Center, Achinoam Faust-Socher, Jeanne Kim, UCLA-Semel Institute, Los Angeles, CA, et al.)

Chapter 2 - Age and Disease Effects on Working Memory; pp. 67-96
(William J. McGeown, Clinical Neuroscience Centre, University of Hull UK, Annalena Venneri, Clinical Neuroscience Centre, University of Hull, UK, Division of Neurology, Department of Neuroscience, University of Modena and Reggio Emilia, Italy)

Chapter 3 - Cognitive Rehabilitation in Middle-Aged Alzheimer Patients; pp. 97-116
(Elisabetta Farina, Fabiana Villanelli, Neurorehabilitation Unit, IRCCS Don Gnocchi Foundation, University of Milan, Italy)

Chapter 4 - Helicobacter Pylori Infection and Alzheimer’s Disease: Correlation of Cerebrospinal Fluid Helicobacter Pylori IgG Antibodies with Disease Severity; pp. 117-136
(Jannis Kountouras, Marina Boziki, Emmanuel Gavalas, Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Greece, et al.)

Chapter 5 - Spatial Correlations Between ß-Amyloid (Aß) Deposits and Blood Vessels in Early-Onset Alzheimer's Disease; pp. 137-153
(R.A. Armstrong, Vision Sciences, Aston University, Birmingham, UK)

Chapter 6 - Aß Immunization in the Treatment of Alzheimer’s Disease; pp. 155-168
(Isidro Ferrer, Institut Neuropatologia, Servei Anatomia Patològica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, Hospitalet de Llobregat, Spain)

Chapter 7 - Estimated Premorbid IQ using Japanese Version of National Adult Reading Test in Individuals with Alzheimer’s Disease; pp. 169-190
(Keiko Matsuoka, Kamata TERAKOYA, Division of Adult Mental Health, National Institute of Mental Health, National Center of Neurology and Psychiatry, Yoshiharu Kim, Division of Adult Mental Health, National Institute of Mental Health, National Center of Neurology and Psychiatry)

Chapter 8 - The Longitudinal Neurodegenerative Impact of Alzheimer’s Disease on Picture Naming; pp. 191-207
(Francisco Javier Moreno-Martínez, Departamento de Psicología Básica I, U.N.E.D. Madrid, Spain, Keith R Laws, School of Psychology, University of Hertfordshire, UK, Miguel Goñi-Imízcoz, Servicio de Neurología, Hospital Divino Vallés, Burgos, Spain, et al.)

Chapter 9 - Differentiating Dementia Syndromes in the Middle-Aged Patient; pp. 209-223
(Cecile A. Marczinski, University of Kentucky, Estee C. Grant, University of Calgary)

Chapter 10 - Mid-Life Transition: Spousal Experiences of Coping With Dementia of the Alzheimer Type; pp. 225-253
(Colleen MacQuarrie)

Chapter 11 - Dementia in the Middle Aged in China; pp. 255-260
(Li Qi, Zhang Lihong and Yew DT)

Chapter 12 - Biomarkers in Alzheimer’s Disease; pp. 261-314
(Amanda McRae, Gershwin K. Davis, Nelleen Baboolal, and John A. Morren, Primary Care Physician, County St. George Central, Trinidad)

Chapter 13 - Evaluation of the Progression of Early-onset Alzheimer Disease by using Diffusion Tensor Imaging; pp. 315-323
(Chen Shaoqiong He Bingjun, Kang Zhuang, Department of Radiology, the Third Affiliated Hospital, Sun Yat-Sen University, P.R.China, et al.)

Chapter 14 - The Psychosocial Neural Sensorial Alternative Alzheimer´s Theory; pp. 325-328
(Luis Sánchez)

Chapter 15 - Early Onset Dementia: Role of Genetics in the Pathogenesis of Alzheimer’s Disease and Frontotemporal Lobar Degeneration; pp. 329-245
(Daniela Galimberti, Chiara Fenoglio, Elio Scarpini, Department of Neurological Sciences, "Dino Ferrari" Center, University of Milan, Italy)

Chapter 16 - Epidemiology of Dementia in a French Speaking Population: High Age-Related Variability of Simple Bedside Tests Efficiencies; pp. 347-353
(Bier J.C., Department of Neurology, Slama H., Van den Berge D., Department of Neuropsychology, ERASME Hospital, Université Libre de Bruxelles, Belgium, et al.)

Index